Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Wonder what the difference is between SEDDS and SNEDDS
View:
Post by mdjbrown on Apr 05, 2024 3:35pm

Wonder what the difference is between SEDDS and SNEDDS

"Avicanna’s proprietary cannabinoid-based Self-Emulsifying Drug Delivery Systems (“SEDDS”) technology capsules for the Canadian and international markets." 


Another Canadian CBD company using similiar delivery tech.

"The research team at EmpowerPharm has developed a novel, patented drug delivery platform using a Self-Nanoemulsifying Drug Delivery System (SNEDDS), which ensures superior bioavailability, consistent potency, extended shelf-life, and stability. This platform has potential applications for enhancing legacy drug molecules."

https://empowerpharm.ca/empowerpharm-awaits-phase-ii-clinical-trial-on-groundbreaking-treatment-to-manage-social-anxiety-disorder/
Comment by subaru1i on Apr 05, 2024 5:12pm
mdjbrown, my take it is the same 'type' of technology but only has 'nano' in it but please recall LABS stating back in 2022 or early 2023 that they developed 'in house' a 'water soluable' solution for higher absorption, less pass through waste, in the human body.   I know that to make CBD or other cannabis molecules 'water soluable' it involves a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities